XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -11.65%71.55B | -45.51%78.43B | -32.11%75.53B | -32.11%75.53B | -23.37%80.01B | -18.61%80.98B | 34.22%143.95B | 6.21%111.26B | 6.21%111.26B | -0.23%104.42B |
-Cash and cash equivalents | 1.02%17.48B | -74.10%20.84B | -47.23%18.32B | -47.23%18.32B | -26.08%19.63B | 10.60%17.31B | 251.56%80.45B | 149.11%34.7B | 149.11%34.7B | 112.53%26.56B |
-Short-term investments | -15.09%54.07B | -9.30%57.59B | -25.26%57.22B | -25.26%57.22B | -22.45%60.38B | -24.06%63.68B | -24.74%63.49B | -15.71%76.55B | -15.71%76.55B | -15.52%77.86B |
Receivables | 12.51%48.19B | 19.47%44.15B | 16.92%56.92B | 16.92%56.92B | 17.66%44.03B | 19.53%42.83B | 18.14%36.95B | 10.00%48.69B | 10.00%48.69B | 14.74%37.42B |
-Accounts receivable | 12.51%48.19B | 19.47%44.15B | 16.92%56.92B | 16.92%56.92B | 17.66%44.03B | 19.53%42.83B | 18.14%36.95B | 10.00%48.69B | 10.00%48.69B | 14.74%37.42B |
Inventory | -43.72%909M | -45.80%1.63B | -50.16%1.25B | -50.16%1.25B | -54.68%1.3B | -45.81%1.62B | -29.71%3B | -33.19%2.5B | -33.19%2.5B | -12.71%2.88B |
Other current assets | 20.51%26.43B | 8.62%25.72B | 19.32%26.02B | 19.32%26.02B | 13.88%21.83B | 12.45%21.93B | 31.54%23.68B | 28.85%21.81B | 28.85%21.81B | 43.88%19.17B |
Total current assets | -0.21%147.08B | -27.78%149.93B | -13.31%159.73B | -13.31%159.73B | -10.20%147.18B | -6.61%147.39B | 29.09%207.59B | 8.59%184.26B | 8.59%184.26B | 6.48%163.89B |
Non current assets | ||||||||||
Net PPE | 47.40%189.72B | 47.02%173.39B | 40.52%154.55B | 40.52%154.55B | 36.01%138.75B | 33.54%128.71B | 30.48%117.94B | 25.63%109.99B | 25.63%109.99B | 22.59%102.01B |
-Gross PPE | 35.15%272.54B | 35.47%253.91B | 29.59%230.97B | 29.59%230.97B | 27.19%213.69B | 26.16%201.66B | 24.10%187.42B | 21.08%178.24B | 21.08%178.24B | 18.93%168.01B |
-Accumulated depreciation | -13.53%-82.82B | -15.88%-80.52B | -11.97%-76.42B | -11.97%-76.42B | -13.56%-74.95B | -14.95%-72.95B | -14.59%-69.49B | -14.40%-68.25B | -14.40%-68.25B | -13.69%-66B |
Goodwill and other intangible assets | -2.86%144.58B | 90.55%146.13B | 90.05%146.82B | 90.05%146.82B | 90.17%147.99B | 90.17%148.83B | -2.02%76.69B | -1.99%77.25B | -1.99%77.25B | -1.14%77.82B |
-Goodwill | 0.22%119.19B | 76.09%119.37B | 75.62%119.22B | 75.62%119.22B | 75.39%119.16B | 75.14%118.93B | 0.49%67.79B | 0.54%67.89B | 0.54%67.89B | 0.84%67.94B |
-Other intangible assets | -15.09%25.39B | 200.74%26.75B | 194.65%27.6B | 194.65%27.6B | 191.81%28.83B | 188.71%29.9B | -17.70%8.9B | -17.10%9.37B | -17.10%9.37B | -12.95%9.88B |
Investments and advances | 16.56%15.58B | 38.12%15.78B | 47.79%14.6B | 47.79%14.6B | 57.27%14.81B | 88.35%13.37B | 67.03%11.42B | 43.36%9.88B | 43.36%9.88B | 36.31%9.42B |
Financial assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Other non current assets | 14.50%36.94B | 17.54%37.79B | 19.15%36.46B | 19.15%36.46B | 31.90%35.55B | 29.09%32.27B | 36.93%32.15B | 39.75%30.6B | 39.75%30.6B | 23.39%26.95B |
Total non current assets | 19.70%386.82B | 56.63%373.09B | 54.76%352.43B | 54.76%352.43B | 55.92%337.1B | 56.32%323.17B | 19.71%238.2B | 16.69%227.72B | 16.69%227.72B | 13.38%216.2B |
Total assets | 13.46%533.9B | 17.32%523.01B | 24.32%512.16B | 24.32%512.16B | 27.41%484.28B | 29.08%470.56B | 23.90%445.79B | 12.92%411.98B | 12.92%411.98B | 10.30%380.09B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 22.07%28.66B | 18.81%32.49B | 21.42%27.01B | 21.42%27.01B | 30.46%25.4B | 24.20%23.48B | 17.16%27.34B | -3.55%22.25B | -3.55%22.25B | -6.09%19.47B |
-accounts payable | 27.76%22.61B | 17.93%22.77B | 21.56%22B | 21.56%22B | 18.18%18.09B | 15.25%17.7B | 16.24%19.31B | -4.76%18.1B | -4.76%18.1B | -4.85%15.31B |
-Total tax payable | 4.65%6.06B | 20.93%9.72B | 20.83%5.02B | 20.83%5.02B | 75.62%7.31B | 62.88%5.79B | 19.41%8.04B | 2.09%4.15B | 2.09%4.15B | -10.40%4.16B |
Current debt and capital lease obligation | -82.08%5.25B | -92.39%2.25B | 70.42%8.94B | 70.42%8.94B | 264.84%22.78B | 632.82%29.29B | 809.98%29.56B | 90.87%5.25B | 90.87%5.25B | 257.06%6.25B |
-Current debt | -82.08%5.25B | -92.39%2.25B | 70.42%8.94B | 70.42%8.94B | 264.84%22.78B | 632.82%29.29B | 809.98%29.56B | 90.87%5.25B | 90.87%5.25B | 257.06%6.25B |
Current deferred liabilities | 5.67%45.51B | 14.21%53.03B | 13.13%57.58B | 13.13%57.58B | 13.51%41.89B | 16.46%43.07B | 12.31%46.43B | 11.78%50.9B | 11.78%50.9B | 8.45%36.9B |
Other current liabilities | 23.98%20.29B | 32.05%19.11B | 30.11%19.19B | 30.11%19.19B | 42.32%18.02B | 27.81%16.36B | 20.04%14.48B | 12.84%14.75B | 12.84%14.75B | 6.73%12.66B |
Current liabilities | -10.03%108.88B | -7.69%115.2B | 20.29%125.29B | 20.29%125.29B | 38.32%118.53B | 48.09%121.02B | 42.80%124.79B | 9.54%104.15B | 9.54%104.15B | 10.66%85.69B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -3.57%56.98B | 6.85%59.23B | 6.34%58.19B | 6.34%58.19B | 5.25%57.13B | 5.29%59.08B | -2.81%55.43B | -6.50%54.72B | -6.50%54.72B | -8.83%54.28B |
-Long term debt | -11.59%39.72B | 2.20%42.87B | 1.66%42.69B | 1.66%42.69B | 1.65%42.66B | 1.83%44.93B | -7.55%41.95B | -10.72%41.99B | -10.72%41.99B | -12.89%41.97B |
-Long term capital lease obligation | 21.89%17.25B | 21.31%16.36B | 21.76%15.5B | 21.76%15.5B | 17.52%14.47B | 17.98%14.16B | 15.67%13.49B | 10.78%12.73B | 10.78%12.73B | 8.41%12.31B |
Non current deferred liabilities | -8.41%5.05B | 62.40%5.24B | 56.05%5.22B | 56.05%5.22B | 80.47%5.41B | 88.00%5.51B | 16.49%3.23B | 7.90%3.35B | 7.90%3.35B | -2.38%3B |
Other non current liabilities | 72.73%35.91B | 67.25%31.17B | 50.51%27.06B | 50.51%27.06B | 33.46%23.27B | 26.14%20.79B | 21.70%18.63B | 15.81%17.98B | 15.81%17.98B | 15.07%17.44B |
Total non current liabilities | 9.93%122.32B | 19.76%120.09B | 16.53%118.4B | 16.53%118.4B | 12.92%112.6B | 11.61%111.27B | 1.47%100.28B | -1.56%101.6B | -1.56%101.6B | -4.35%99.71B |
Total liabilities | -0.47%231.2B | 4.54%235.29B | 18.44%243.69B | 18.44%243.69B | 24.66%231.12B | 28.04%232.29B | 20.86%225.07B | 3.76%205.75B | 3.76%205.75B | 2.05%185.41B |
Shareholders'equity | ||||||||||
Share capital | 7.54%104.83B | 7.82%102.98B | 7.69%100.92B | 7.69%100.92B | 7.71%99.19B | 8.04%97.48B | 7.88%95.51B | 7.80%93.72B | 7.80%93.72B | 7.38%92.09B |
-common stock | 7.54%104.83B | 7.82%102.98B | 7.69%100.92B | 7.69%100.92B | 7.71%99.19B | 8.04%97.48B | 7.88%95.51B | 7.80%93.72B | 7.80%93.72B | 7.38%92.09B |
Retained earnings | 39.62%203.48B | 42.97%188.93B | 45.69%173.14B | 45.69%173.14B | 47.27%159.39B | 46.66%145.74B | 43.05%132.14B | 41.01%118.85B | 41.01%118.85B | 35.92%108.23B |
Gains losses not affecting retained earnings | -13.48%-5.62B | 39.71%-4.18B | 11.87%-5.59B | 11.87%-5.59B | 3.70%-5.44B | 23.35%-4.95B | 5.53%-6.94B | -35.59%-6.34B | -35.59%-6.34B | -127.95%-5.64B |
Total stockholders'equity | 27.04%302.7B | 30.36%287.72B | 30.19%268.48B | 30.19%268.48B | 30.03%253.15B | 30.10%238.27B | 27.16%220.71B | 23.83%206.22B | 23.83%206.22B | 19.49%194.68B |
Total equity | 27.04%302.7B | 30.36%287.72B | 30.19%268.48B | 30.19%268.48B | 30.03%253.15B | 30.10%238.27B | 27.16%220.71B | 23.83%206.22B | 23.83%206.22B | 19.49%194.68B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |